CDC Warns Americans About Chikungunya Virus Outbreak in China
The warning comes as a mosquito-borne virus called chikungunya spreads quickly through parts of the Eastern country.
The CDC issued the travel warning this month after cases started rising fast in Guangdong province. Most reports come from the city of Foshan, where Chinese health officials have counted more than 7,000 confirmed cases since June.
Chikungunya virus spreads through mosquito bites. Most people who catch the virus develop symptoms within three to seven days after an infected mosquito bites them.
The most common signs include fever and severe joint pain, with people also reporting headaches, muscle pain, swollen joints, and skin rashes.
While most patients recover within a week, some suffer from joint pain for months or even years.
The CDC warns that certain groups face higher risks, including newborn babies, adults over 65, and people with diabetes or heart disease.
Deaths from chikungunya remain rare, but doctors have no specific treatment for the virus.
Local authorities in Foshan have launched a large campaign against mosquitoes. Workers send drones into the sky to find places where mosquitoes breed.
They spray residents with mosquito repellent before people can enter buildings. Officials also release mosquito-eating fish into ponds and other water sources.
The outbreak in China forms part of a larger global problem. The European Centre for Disease Prevention and Control reports about 240,000 cases worldwide across 16 countries and territories. These cases have been linked to 90 deaths so far this year.
The CDC said outbreaks also affect Bolivia, Kenya, and Sri Lanka, saying that Americans traveling to Brazil, Colombia, India, Mexico, Nigeria, Pakistan, the Philippines, and Thailand face higher chances of catching the virus.
How to stay safe
Health officials recommend several ways to avoid mosquito bites. Travelers should use insect repellent and wear long-sleeved shirts and long pants. They should stay in places with air conditioning or screens on windows and doors.
The CDC also suggests getting vaccinated. Two chikungunya vaccines have approval for use in the US. Officials recommend vaccination for anyone visiting areas with active outbreaks.
Travelers should watch for warning signs during and after their trips. Anyone who develops fever, joint pain, headaches, muscle pain, joint swelling, or rashes should see a doctor right away. Tags: chikungunyachikungunya virusChinaUS citizens
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Morocco World
4 days ago
- Morocco World
CDC Warns Americans About Chikungunya Virus Outbreak in China
Rabat — The U.S. Centers for Disease Control and Prevention (CDC) has advised US citizens to exercise extra caution when traveling to China. The warning comes as a mosquito-borne virus called chikungunya spreads quickly through parts of the Eastern country. The CDC issued the travel warning this month after cases started rising fast in Guangdong province. Most reports come from the city of Foshan, where Chinese health officials have counted more than 7,000 confirmed cases since June. Chikungunya virus spreads through mosquito bites. Most people who catch the virus develop symptoms within three to seven days after an infected mosquito bites them. The most common signs include fever and severe joint pain, with people also reporting headaches, muscle pain, swollen joints, and skin rashes. While most patients recover within a week, some suffer from joint pain for months or even years. The CDC warns that certain groups face higher risks, including newborn babies, adults over 65, and people with diabetes or heart disease. Deaths from chikungunya remain rare, but doctors have no specific treatment for the virus. Local authorities in Foshan have launched a large campaign against mosquitoes. Workers send drones into the sky to find places where mosquitoes breed. They spray residents with mosquito repellent before people can enter buildings. Officials also release mosquito-eating fish into ponds and other water sources. The outbreak in China forms part of a larger global problem. The European Centre for Disease Prevention and Control reports about 240,000 cases worldwide across 16 countries and territories. These cases have been linked to 90 deaths so far this year. The CDC said outbreaks also affect Bolivia, Kenya, and Sri Lanka, saying that Americans traveling to Brazil, Colombia, India, Mexico, Nigeria, Pakistan, the Philippines, and Thailand face higher chances of catching the virus. How to stay safe Health officials recommend several ways to avoid mosquito bites. Travelers should use insect repellent and wear long-sleeved shirts and long pants. They should stay in places with air conditioning or screens on windows and doors. The CDC also suggests getting vaccinated. Two chikungunya vaccines have approval for use in the US. Officials recommend vaccination for anyone visiting areas with active outbreaks. Travelers should watch for warning signs during and after their trips. Anyone who develops fever, joint pain, headaches, muscle pain, joint swelling, or rashes should see a doctor right away. Tags: chikungunyachikungunya virusChinaUS citizens
Alalam24
6 days ago
- Alalam24
A Chinese Innovation Opens New Horizons in Obesity Treatment
Chinese scientists have made a major breakthrough in the fight against obesity by developing a new drug, Mazdutide, which has shown remarkable effectiveness in reducing body weight and improving metabolic health indicators. Professor Ji Linong, head of the research team and director of the Department of Endocrinology at Peking University People's Hospital, stated that results from the Phase III clinical trials—recently published in the New England Journal of Medicine—demonstrate that the drug not only aids in weight loss but also helps improve cholesterol levels, reduce waist circumference, regulate blood pressure, and lower uric acid levels. Xiao Rui-Ping, deputy editor-in-chief of the same medical journal, emphasized that this discovery strengthens China's position at the forefront of nations leading locally developed obesity treatments. According to medical reports, obesity poses a growing global health threat, with estimates suggesting that more than 50% of adults worldwide will be overweight or obese by 2050. In China, obesity rates have more than doubled over the past four decades, exacerbating risks associated with conditions such as diabetes, cardiovascular diseases, and certain types of cancer, while also reducing life expectancy. In response to this challenge, both local and international pharmaceutical companies have intensified efforts to develop effective drug treatments. In 2024, Chinese health authorities included anti-obesity drugs in their official treatment guidelines, approving five medications so far, most notably Semaglutide and Orlistat, which are currently available in the Chinese market. Despite their effectiveness, experts stress that drug therapies alone are not a complete solution. They must be combined with other strategies—such as lifestyle changes, dietary adjustments, and physical activity—to achieve sustainable results. To support this approach, China has launched national campaigns, including the establishment of weight management clinics in hospitals, the publication of official dietary guidelines, and the implementation of mandatory daily physical education in schools. Furthermore, since 2008, the country has observed an annual National Fitness Day on August 8, reflecting its commitment to promoting healthy lifestyles. In summary, Mazdutide marks a promising step forward in tackling obesity, yet it remains part of a broader, integrated strategy requiring collective and individual efforts.
Morocco World
23-07-2025
- Morocco World
Morocco Partners with AstraZeneca to Strengthen Healthcare for Rare Diseases
Rabat – The Mohammed VI Foundation for Science and Health and AstraZeneca signed today a Memorandum of Understanding (MoU), paying special attention to improving the diagnosis and treatment of rare diseases in Morocco. Rami Scandar, Regional President of AstraZeneca Near East & Maghreb, commended the signing of the agreement, explaining that it covers five key pillars to tackle major challenges faced by patients with rare diseases in Morocco. The agreement aims to help accelerate diagnosis, enhancing the education and training of physicians and nurses, improving access to innovative medicines and therapies, and strengthening overall patient care, he stressed. It covers cooperative efforts benefiting patients across Morocco to address critical gaps in the healthcare system and advance rare disease awareness and care nationwide. Saber Boutayeb, the director of the Mohammed VI Center for Research and Innovation, told Morocco World News (MWN) that the contract with AstraZeneca follows more than a year of cooperation and ongoing participation. Boutayeb emphasized that the partnership with AstraZeneca will leverage combined expertise and resources to enhance the diagnosis and treatment of rare diseases in Morocco. 'Today, we are moving into a more practical phase, combining the high-level expertise developed here at the center with the medical expertise and scientific research capabilities of AstraZeneca,' Boutayeb said. The cooperation will also be open to other partners like hospitals affiliated with the Mohammed VI Foundation and other centers, he explained. Also known as orphan diseases, rare diseases affect a small percentage of the world's population. According to the Organization for Rare Disorders, there are more than 10,000 diseases that affect over 30 million Americans . Morocco signed in 2019 an agreement seeking to help people living with rare diseases. The agreement mainly aimed to improve the existing medical infrastructure by launching specialized centers at major university hospitals. The plan also sought to create a national registry for rare diseases to better track and predict their incidence. Tags: AstrazenecaOxford/AstraZeneca
